NCT02141659View on ClinicalTrials.gov

A Study of TAK-385 in Hormone Treatment-naïve Participants With Prostate Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

43

Participants

Timeline

Start Date

May 1, 2014

Primary Completion Date

April 20, 2017

Study Completion Date

April 20, 2017

Conditions

Hormone Treatment-naïve Participants With Prostate Cancer

Interventions

DRUG

TAK-385

TAK-385 Tablets.

Trial Locations (6)

Unknown

Sakura-shi

Maebashi

Sapporo

Kanazawa

Yokohama

Chiyoda-ku

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY

NCT02141659 - A Study of TAK-385 in Hormone Treatment-naïve Participants With Prostate Cancer | Biotech Hunter | Biotech Hunter